Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The dystrophin gene (DMD) pre-mRNA is the primary transcript of the largest known human gene, located on the X chromosome. It undergoes extensive splicing to generate mature mRNA that encodes the dystrophin protein, essential for muscle cell membrane stabilization. Mutations affecting splicing or sequence integrity of the pre-mRNA cause Duchenne and Becker muscular dystrophies. Therapeutic strategies targeting the pre-mRNA aim to modulate splicing and restore functional dystrophin protein production.
Exon skipping via antisense oligonucleotide binding to splice sites, promoting exclusion of targeted exons during pre-mRNA processing.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dystrophin Gene pre-mRNA (DMD pre-mRNA).